U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07006285) titled 'T2 Biomarkers Predictive Value in Occupational Asthma After Cessation of Exposure.' on Nov. 08, 2024.
Brief Summary: Occupational exposure is known to cause 15% of asthma cases. The main treatment for occupational asthma is to stop exposure if possible. Although, remission of occupational asthma only occurs in only 30 % of patients after cessation of exposure. There is currently no way of predicting which patients will go into remission after cessation of exposure.
In non-occupational asthma, the inflammatory biomarker T2 has allowed the entry into personalized medicine and can predict future exacerbations.
The investigators hypoth...